Erenumab 70 mg

DRUG2 trials

Sponsors

Amgen, Stanford University

Conditions

MigraineMigraine Associated VertigoMigraine HeadacheTinnitusVestibular Migraine

Phase 4

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

CompletedNCT03971071

AmgenMigraine Headache

Start: 2019-10-07End: 2023-06-13Updated: 2025-09-19

Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

Not yet recruitingNCT07655440

Stanford UniversityMigraine, Migraine Associated Vertigo, Tinnitus +1

Start: 2026-07-01End: 2031-07-01Target: 120Updated: 2026-06-17

Related Papers

Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo‐Controlled Study

European Journal of Neurology2025-08-01

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine

JAMA Neurology2024-09-1615 citations